Scholarlink

<p>Recent data presented at ASCO 2025 highlighted important advances in the treatment of ovarian cancer. The results of three key studies—TRUST, FIRST, and ROSELLA—provide new insights into optimal surgical strategies, the emerging role of immunotherapy, and novel systemic treatment options for platinum-resistant disease. This review summarizes these findings and discusses their potential impact on clinical practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Highlights from ASCO 2025—advances in the treatment of ovarian cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月11日

查看全文
  • Stephan Polterauer

摘要

Recent data presented at ASCO 2025 highlighted important advances in the treatment of ovarian cancer. The results of three key studies—TRUST, FIRST, and ROSELLA—provide new insights into optimal surgical strategies, the emerging role of immunotherapy, and novel systemic treatment options for platinum-resistant disease. This review summarizes these findings and discusses their potential impact on clinical practice.